Diane E. Wilfong - 10 Sep 2025 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Interim Corp Controller & CAO
Signature
/s/ Edward S. Son by Power of Attorney for Diane E. Wilfong
Issuer symbol
GILD
Transactions as of
10 Sep 2025
Transactions value $
-$38,955
Form type
4
Filing time
11 Sep 2025, 19:34:04 UTC
Previous filing
11 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wilfong Diane E. Interim Corp Controller & CAO GILEAD SCIENCES, INC., 333 LAKESIDE DRIVE, FOSTER CITY /s/ Edward S. Son by Power of Attorney for Diane E. Wilfong 11 Sep 2025 0001374988

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +921 +2.02% 46.6K 10 Sep 2025 Direct F1
transaction GILD Common Stock Tax liability -$39K -338 -0.73% $115.25 46.3K 10 Sep 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -921 -10.48% 7.86K 10 Sep 2025 Common Stock 921 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.